University of Arizona BIO5 Institute, Room 103
Thomas W. Keating Bioresearch Building
1657 E. Helen St.
Tucson, AZ 85721
Brought to you by the Arizona Center for the Biology of Complex Diseases (ABCD) at the University of Arizona:
TOPIC: “Biology of Complex Diseases: Wrap-Up”
SPEAKER: Donata Vercelli, PhD — Professor, Cellular and Molecular Medicine, UA College of Medicine – Tucson | Associate Director, Asthma and Airway Disease Research Center, UA Health Sciences | Director, Arizona Center for the Biology of Complex Diseases, University of Arizona
WHEN: Friday, April 26, 2018 | 9-11 a.m.
WHERE: BIO5 Room 103
Weekly Colloquium, Spring 2019 – Problems in the Biology of Complex Diseases
(CMM, MCB, GENE, IMB, PCOL 595H)
Fridays, 9-11 a.m., Keating/BIO5 Room 103, Jan. 11-April 26 (except for March 1, 9-11 a.m., Keating/BIO5 Room 247)
SPEAKERS SCHEDULE: Click here [PDF] for a printable schedule for the entire series.
About the Speaker
Dr. Vercelli received her medical degree from the University of Florence in Italy in 1978 and trained in immunology at Children’s Hospital/Harvard Medical School in Boston, where she was an Assistant Professor of Pediatrics from 1991 to 1994. After four years as Director of the Molecular Immunoregulation Unit at San Raffaele Scientific Institute in Milan, she moved in 1999 to the University of Arizona where she currently is a Professor of Cellular and Molecular Medicine, the Associate Director of the Asthma and Airway Disease Research Center, and the Director of the Arizona Center for the Biology of Complex Diseases (ABCD). She is an elected member of the Association of American Physicians (AAP) and from 2005 to 2012 was the Associate Editor for Genetics of The Journal of Allergy and Clinical Immunology. In 2018, she was elected the first female Secretary General of the International Allergy Collegium — a group of distinguished international physicians and scientists formed in 1954 who study the emerging field of allergy and clinical immunology. Her research relies on both human and animal models and is supported by the NIH and industry.